COX Inhibitors and Blood Coagulation PHM 142 – Tuesday September 16 th, 2014 Chris Gallant Edmond...
-
Upload
jakob-arter -
Category
Documents
-
view
216 -
download
2
Transcript of COX Inhibitors and Blood Coagulation PHM 142 – Tuesday September 16 th, 2014 Chris Gallant Edmond...
COX Inhibitors and Blood Coagulation
PHM 142 – Tuesday September 16th, 2014
Chris GallantEdmond Chiu
Maggie HuynhBavithra Kumar
PHM142 Fall 2014 Instructor: Dr. Jeffrey Henderson
What is COX?• Enzyme cyclooxygenase 1
• Responsible for the formation of prostanoids1
• 3 main groups of prostanoids include:• prostaglandins• prostacyclins• thromboxanes
*These are all involved in inflammatory responses/are inflammatory mediators*
What is COX?
Two forms of cyclooxygenase enzymes exist:
COX-1 -> present in most tissues1
● e.g in GI tract it maintains the normal lining of the stomach. The enzyme is also involved in kidney and platelet function. 2,3
COX-2 -> primarily present at sites of inflammation1
COX’s Relationship to Blood Coagulation
● COX plays a role in cessation of bleeding 4-6
● COX activates a chemical known as thromboxane A2 4-6
● The aggregation of platelets, in concert with the clotting process, results in a fibrin clot which stops bleeding and aids repair of the blood vessel. 7
What are COX inhibitors?• A class of drugs that target the cyclooxygenase
enzyme and act as an effective treatment to pain and inflammation. Also known as nonsteroidal anti-inflammatory drugs (NSAIDs).8
• Can be nonspecific (target both COX-1 and COX-2) or specifically target COX-2.8
• COX-2 inhibition is desirable since this will reduce pain and inflammation in certain areas, while COX-1 inhibition is associated with side effects, such as stomach lining damage and gastric ulcers.8
http://img.wikinut.com/img/297i4cfbldfkof_v/jpeg/0/Ibuprofen-Advil-tablets.jpeghttp://a.espncdn.com/photo/2007/1112/pg2_a_aleve_300.jpg
How COX Inhibitors Work• Decrease the production of
prostaglandins, which promote pain, inflammation and fever.9
• Prostaglandins also protect the lining of the stomach and intestines, promote blood clotting, and affect kidney function.9
• COX inhibitors are taken orally, and after absorption into the bloodstream they bind to the cyclooxygenase enzymes. COX-1 is found in all tissues constitutively, while COX-2 is induced by inflammation.9
• Binding can be reversible or irreversible.7
http://www.cheapmedicinechest.com/wp-content/uploads/2010/03/Figure-2-Nonselective-nonsteroidal-anti-inflammatory-drugs.pnghttp://publications.nigms.nih.gov/structlife/images/ch4_valine.gif
Aspirin and COX: Mechanism of Action
• Serine acetylation3
• Non-selective3
• Irreversible3
Adapted from reference 4
Issues with COX-2 specific inhibitors• COX-2 inhibition
reduces prostacyclin production, which is an important prostaglandin that prevents platelet clumping.9
• Without prostacyclin, platelets can build up and clump, leading to increased heart attacks and strokes in patients. Since COX-1 is unaffected, thromboxane A2 contributes to thrombosis as well.9
• Examples are Vioxx and Bextra, which have both been discontinued.9
http://img.timeinc.net/time/covers/1101050228/map/viox.gif
Case StudyCOX-2 inhibitors used to treat
pain after surgery 10,11
Possible complications?◦Increased risk of thrombosis
Concern in Coronary-Artery Bypass Grafting (CABG)?
Factors ConsideredCABG increases thromboembolic
events:◦Platelet activation
Pre-exisiting cardiovascular conditions12
Sheer stress from atherosclerosis
◦Ischemia13
During procedure14
COX-2 inhibitors increase risk of thrombosis
Conclusion of Study
Risk outweighs benefits16
Advised to discontinue use of COX-2 specific inhibitors after CABG16
◦Drug discontinued in 2005
Summary SlideCOX is an enzyme cyclooxygenase responsible
for the formation of prostanoids which are involved in inflammatory response
COX plays a role in cessation of bleeding and activates a chemical known as thromboxane A2 which relates to blood coagulation and platelet aggregation
COX inhibitors nonspecifically bind to COX-1 and COX-2 or specifically bind to COX-2. Binding to COX-2 is desirable for reducing inflammation, pain and fever as it also avoids gastric ulceration. This effect is caused by reducing prostaglandin production.
COX-2 inhibitors should be avoided when risk of thromboembolic events is higher
References1. Eustice, C. (2014, May 19). What Is Cyclooxygenase (COX)?. About Health . Retrieved
September 15, 2014, from http://osteoarthritis.about.com/od/osteoart2. Lipsky, A. J. (n.d.). Clinical Considerations for Gastric Protection in the Presence of
NSAID Therapy. Medscape. Retrieved September 15, 2014, from http://www.medscape.org/viewarticle/4739
3. University, Department of Epidemiology and Preventative Medicine. (n.d.). How Aspirin Works. How Aspirin Works. Retrieved September 15, 2014 from http://www.aspree.org/AUS/aspree- content/aspirin/how-aspirin-works.aspx
4. Ophardt, Charles. "Prostaglandins." Virtual Chembook. N.p., n.d. Web. 15 Sept. 2014. <http://www.elmhurst.edu/~chm/vchembook/555prostagland.html>.
5. "How The Blood Clots." How Does Blood Clot? Coagulation Explained, Diagram, Blood Clotting Process, Stages, Hemostasis. N.p., 2010. Web. 15 Sept. 2014.
6. Rhoades, Rodney , and David Bell. "Blood Clotting." Inkling. Wolters Kluwer, n.d. Web. 15 Sept. 2014. https://www.inkling.com/read/medical-physiology-rodney-rhoades-david-bell-4th/chapter-9/blood- clotting.
7. Stenina, Olga, and Edward Plow. "MET orchestrates cancer and blood coagulation." Nature.com. Nature Publishing Group, n.d. Web. 15 Sept. 2014. <http://www.nature.com/nm/journal/v11/n4/fig_tab/nm0405- 376_F1.html>.
8. McGettigan, P. and Henry, D. (2000). Current problems with non-specific COX inhibitors. Curr Pharm Des, 6(17): 1693-1724.
9. Eustice, Carol. Cyclooxygenase: COX-1 and COX-2 explained. About Health, http://osteoarthritis.about.com/od/osteoarthritismedications/a/cyclooxygenase.htm (accessed September 10th, 2014).
References10.Daniels, S. E., Grossman, E. H., Kuss, M. E., Talwalker, S., & Hubbard,
R. C. (2001). A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post—oral surgery pain model. Clinical therapeutics, 23(7), 1018-1031.
11.Ng, A., Smith, G., & Davidson, A. C. (2003). Analgesic effects of parecoxib following total abdominal hysterectomy†‡. British Journal of Anaesthesia, 90(6), 746-749.
12.Konstantopoulos, K., Grotta, J. C., Sills, C., Wu, K. K., & Hellums, J. D. (1995). Shear- induced platelet aggregation in normal subjects and stroke patients.Thrombosis and haemostasis, 74(5), 1329-1334.
13.Park, J. L., & Lucchesi, B. R. (1999). Mechanisms of myocardial reperfusion injury. The Annals of thoracic surgery, 68(5), 1905-1912.
14.Wan, S., LeClerc, J. L., & Vincent, J. L. (1997). Inflammatory response to cardiopulmonary bypass mechanisms involved and possible therapeutic strategies. CHEST Journal, 112(3), 676-692.
15.Nussmeier, N. A., Whelton, A. A., Brown, M. T., Langford, R. M., Hoeft, A., Parlow, J. L., ... & Verburg, K. M. (2005). Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. New England Journal of Medicine, 352(11), 1081- 1091.